Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP)
LSE:BXP
Holding GB:BXP?
Track your performance easily

Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP) Share Price & Analysis

5 Followers

BXP Stock Chart & Stats


Financials

Annual

BXP FAQ

What was Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price range in the past 12 months?
Beximco Pharmaceuticals Limited Sponsored GDR RegS lowest share price was 19.32p and its highest was 45.00p in the past 12 months.
    What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s market cap?
    Currently, no data Available
    When is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date?
    Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date is Nov 07, 2024 which is in 7 days.
      How were Beximco Pharmaceuticals Limited Sponsored GDR RegS’s earnings last quarter?
      Beximco Pharmaceuticals Limited Sponsored GDR RegS released its earnings results on Apr 30, 2024. The company reported 0.023p earnings per share for the quarter, beating the consensus estimate of N/A by 0.023p.
        Is Beximco Pharmaceuticals Limited Sponsored GDR RegS overvalued?
        According to Wall Street analysts Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Beximco Pharmaceuticals Limited Sponsored GDR RegS pay dividends?
          Beximco Pharmaceuticals Limited Sponsored GDR RegS pays a Annually dividend of 2.09p which represents an annual dividend yield of 6.83%. See more information on Beximco Pharmaceuticals Limited Sponsored GDR RegS dividends here
            What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate?
            Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Beximco Pharmaceuticals Limited Sponsored GDR RegS have?
            Beximco Pharmaceuticals Limited Sponsored GDR RegS has 446,112,100 shares outstanding.
              What happened to Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price movement after its last earnings report?
              Beximco Pharmaceuticals Limited Sponsored GDR RegS reported an EPS of 0.023p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Beximco Pharmaceuticals Limited Sponsored GDR RegS?
                Currently, no hedge funds are holding shares in GB:BXP
                ---

                Beximco Pharmaceuticals Limited Sponsored GDR RegS Stock Smart Score

                Company Description

                Beximco Pharmaceuticals Limited Sponsored GDR RegS

                Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                AstraZeneca
                Hikma Pharmaceuticals
                Indivior
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis